Brent A. Moore

7.1k total citations
109 papers, 5.2k citations indexed

About

Brent A. Moore is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Pharmacology. According to data from OpenAlex, Brent A. Moore has authored 109 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Epidemiology, 47 papers in Public Health, Environmental and Occupational Health and 27 papers in Pharmacology. Recurrent topics in Brent A. Moore's work include Opioid Use Disorder Treatment (44 papers), Substance Abuse Treatment and Outcomes (36 papers) and Cannabis and Cannabinoid Research (17 papers). Brent A. Moore is often cited by papers focused on Opioid Use Disorder Treatment (44 papers), Substance Abuse Treatment and Outcomes (36 papers) and Cannabis and Cannabinoid Research (17 papers). Brent A. Moore collaborates with scholars based in United States, Canada and Brazil. Brent A. Moore's co-authors include Alan J. Budney, David A. Fiellin, John R. Hughes, Richard S. Schottenfeld, Ryan G. Vandrey, Declan T. Barry, Patrick G. O’Connor, Lynn E. Sullivan, Marek C. Chawarski and Christopher J. Cutter and has published in prestigious journals such as New England Journal of Medicine, American Journal of Psychiatry and Clinical Infectious Diseases.

In The Last Decade

Brent A. Moore

107 papers receiving 5.0k citations

Peers

Countries citing papers authored by Brent A. Moore

Since Specialization

Citations

This map shows the geographic impact of Brent A. Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brent A. Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brent A. Moore more than expected).

Fields of papers citing papers by Brent A. Moore

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brent A. Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brent A. Moore. The network helps show where Brent A. Moore may publish in the future.

Co-authorship network of co-authors of Brent A. Moore

This figure shows the co-authorship network connecting the top 25 collaborators of Brent A. Moore. A scholar is included among the top collaborators of Brent A. Moore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brent A. Moore. Brent A. Moore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Substance Use–Related Continuing Education Course Objectives: Alignment with Professional Competencies 2022 ·Substance Abuse ·Deborah S. Finnell, (unknown), Jeffrey Bratberg, Andrew J. Muzyk, Yifei Liu, Ellen L. Edens, J. Paul Seale, (unknown), (unknown), (unknown), Allen Zweben, Ann H. Cary, Brent A. Moore	1
2	Opioid tapering support using a web-based app: Development and protocol for a pilot randomized controlled trial 2022 ·Contemporary Clinical Trials ·Sara N. Edmond, (unknown), Brent A. Moore, (unknown), (unknown), Liana Fraenkel, William C. Becker	3
3	A multi-center outbreak of Candida tropicalis bloodstream infections associated with contaminated hemodialysis machine prime buckets 2021 ·American Journal of Infection Control ·John M. Boyce, Diane G. Dumigan, Nancy L. Havill, R. J. Hollis, Michael A. Pfaller, Brent A. Moore	8
4	Microbial burden on environmental surfaces in patient rooms before daily cleaning—Analysis of multiple confounding variables 2021 ·Infection Control and Hospital Epidemiology ·John M. Boyce, Nancy L. Havill, (unknown), Brent A. Moore	4
5	Predictors of timely opioid agonist treatment initiation among veterans with and without HIV 2019 ·Drug and Alcohol Dependence ·Jessica J. Wyse, (unknown), Kathleen A. McGinnis, E. Jennifer Edelman, Adam J. Gordon, Ajay Manhapra, David A. Fiellin, Brent A. Moore, P. Todd Korthuis, Julie R. Gaither, Kirsha S. Gordon, Melissa Skanderson, Declan T. Barry, Stephen Crystal, Amy C. Justice, Kevin L. Kraemer	28
6	A Remotely-Delivered CBT and Contingency Management Therapy for Substance Using People with HIV 2015 ·AIDS and Behavior ·Brent A. Moore, Marc I. Rosen, Yan Wang, Jie Shen, (unknown), (unknown), Mario Guerrero, (unknown), Eric S. Daar, Honghu Liu	22
7	Bridging waitlist delays with interim buprenorphine treatment: Initial feasibility 2015 ·Addictive Behaviors ·Stacey C. Sigmon, Andrew C. Meyer, Bryce Hruska, Taylor A. Ochalek, Gail L. Rose, Gary J. Badger, John R. Brooklyn, Sarah H. Heil, Stephen T. Higgins, Brent A. Moore, Robert P. Schwartz	26
8	Factors Associated with Money Mismanagement Among Adults with Severe Mental Illness and Substance Abuse 2015 ·International Journal of Mental Health and Addiction ·Brent A. Moore, Anne C. Black, Marc I. Rosen	3
9	A pilot trial of a videogame-based exercise program for methadone maintained patients 2014 ·Journal of Substance Abuse Treatment ·Christopher J. Cutter, Richard S. Schottenfeld, Brent A. Moore, Samuel A. Ball, Mark Beitel, Jonathan D. Savant, Matthew Stults‐Kolehmainen, (unknown), Declan T. Barry	45
10	Evaluation of two organosilane products for sustained antimicrobial activity on high-touch surfaces in patient rooms 2014 ·American Journal of Infection Control ·John M. Boyce, Nancy L. Havill, (unknown), Steven J. Schweon, Brent A. Moore	19
11	Brief versus extended counseling along with buprenorphine/naloxone for HIV-infected opioid dependent patients 2012 ·Journal of Substance Abuse Treatment ·Jeanette M. Tetrault, Brent A. Moore, Declan T. Barry, Patrick G. O’Connor, Richard S. Schottenfeld, David A. Fiellin, Lynn E. Fiellin	34
12	Cost-Effectiveness of Long-Term Outpatient Buprenorphine-Naloxone Treatment for Opioid Dependence in Primary Care 2012 ·Journal of General Internal Medicine ·Bruce R. Schackman, Jared A. Leff, Daniel Polsky, Brent A. Moore, David A. Fiellin	86
13	Human Immunodeficiency Virus Testing Practices Among Buprenorphine-prescribing Physicians 2012 ·Journal of Addiction Medicine ·E. Jennifer Edelman, (unknown), Brent A. Moore, Richard S. Schottenfeld, David A. Fiellin, Lynn E. Sullivan	12
14	Personality Disorders and Retention in a Therapeutic Community for Substance Dependence 2011 ·American Journal on Addictions ·Douglas B. Samuel, Donna M. LaPaglia, (unknown), Brent A. Moore, Samuel A. Ball	40
15	Terminal Decontamination of Patient Rooms Using an Automated Mobile UV Light Unit 2011 ·Infection Control and Hospital Epidemiology ·John M. Boyce, Nancy L. Havill, Brent A. Moore	85
16	The Association between Cocaine Use and Treatment Outcomes in Patients Receiving Office‐Based Buprenorphine/Naloxone for the Treatment of Opioid Dependence 2009 ·American Journal on Addictions ·Lynn E. Sullivan, Brent A. Moore, Patrick G. O’Connor, Declan T. Barry, Marek C. Chawarski, Richard S. Schottenfeld, David A. Fiellin	55
17	Routine Anal Cytology Screening for Anal Squamous Intraepithelial Lesions in an Urban HIV Clinic 2008 ·Sexually Transmitted Diseases ·Hyman Scott, (unknown), Brent A. Moore, Sharon Weissman	38
18	Response to hepatitis A vaccine in HIV‐positive patients¹ 2005 ·Journal of Viral Hepatitis ·Sharon Weissman, Cynthia Feucht, Brent A. Moore	56
19	The time course and significance of cannabis withdrawal. 2003 ·Journal of Abnormal Psychology ·Alan J. Budney, Brent A. Moore, Ryan G. Vandrey, John R. Hughes	342
20	Community hospitals for the new millennium. 2001 ·PubMed ·David Seamark, Brent A. Moore, Helen Tucker, J. C. T. Church, Clare Seamark	30

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact